MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)

Trial Identifier: 8527-004
Sponsor: MSD
Start Date: November 2022
Primary Completion Date: January 2024
Study Completion Date: January 2024
Condition: Human Immunodeficiency Virus (HIV)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Results Plain Language Summary - EMEA Zulu
Results Plain Language Summary - EMEA Sesotho
Results Plain Language Summary - EMEA Afrikaans
Results Plain Language Summary - EMEA Xhosa
Results Plain Language Summary - EU Romanian

Trial Locations

Country Location
Romania, Bucuresti București, Bucuresti, Romania
South Africa, Free State Bloemfontein, Free State, South Africa, 9301
South Africa, Gauteng Johannesburg, Gauteng, South Africa, 2092
South Africa, Western Cape Cape Town, Western Cape, South Africa, 7925